Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.60
Bid: 1,705.40
Ask: 1,706.00
Change: 0.40 (0.02%)
Spread: 0.60 (0.035%)
Open: 1,701.60
High: 1,708.60
Low: 1,699.40
Prev. Close: 1,705.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

26 Sep 2022 11:19

Unilever's soap opera: M&A, Nelson Peltz, CEO to retire

Sept 26 (Reuters) - Unilever CEO Alan Jope plans to retire at the end of 2023 roughly two months after activist investor Nelson Peltz joined the board of the consumer goods company.

Read more
26 Sep 2022 11:00

Unilever CEO set to leave after GSK debacle, arrival of activist investor

CEO Jope to retire at end 2023

*

Read more
26 Sep 2022 09:11

TOP NEWS: Unilever CEO Alan Jope to step down next year

(Alliance News) - Unilever PLC on Monday said Chief Executive Alan Jope will step down at the end of next year, after five years in the post.

Read more
26 Sep 2022 08:55

TOP NEWS: GSK names Burberry's Julie Brown as new CFO from May

(Alliance News) - GSK PLC on Monday announced a change in leadership, after its Chief Financial Officer Iain Mackay decided to retire.

Read more
26 Sep 2022 08:21

GSK looks to Burberry for new CFO

(Sharecast News) - GSK has named Burberry Group's Julie Brown as its new chief financial officer.

Read more
26 Sep 2022 07:47

LONDON BRIEFING: Unilever CEO to step down; RPS backs new takeover bid

(Alliance News) - All eyes will be on the pound when traders in Europe return to desks on Monday, after the UK currency fell to an all-time low during the Asian session.

Read more
24 Sep 2022 17:57

GSK poaches Burberry CFO Julie Brown to create all-female top team - Sky News

Sept 24 (Reuters) - British drugmaker GSK plc has poached Burberry Group's finance chief to create a rare all-female executive leadership team, Sky News reported on Saturday.

Read more
24 Sep 2022 17:32

GSK poaches Burberry CFO Julie Brown to create all-female top team - Sky News

Sept 24 (Reuters) - British drugmaker GSK plc, has poached Burberry Group's finance chief to create a rare all-female executive leadership team, Sky News reported on Saturday.

Read more
23 Sep 2022 06:57

GSK cancer drug Zejula to be reviewed by US health watchdog

(Alliance News) - GSK PLC on Thursday said its cancer drug Zejula will be reviewed by the US Food & Drug Administration for overall survival data for patients with ovarian cancer.

Read more
22 Sep 2022 08:43

TOP NEWS: GSK signs licence deal for Spero's tebipenem HBr antibiotic

(Alliance News) - GSK PLC on Thursday said it has signed an exclusive licence agreement with Massachusetts-based biotechnology firm Spero Therapeutics for the latter's tebipenem pivoxil hydrobromide, or tebipenem HBr.

Read more
22 Sep 2022 07:47

GSK takes stake in Spero in deal on UTI treatment

(Sharecast News) - UK pharmaceutical company GSK is taking a stake in Spero Therapeutics as part of a licensing agreement for the US-based drug developer's experimental antibiotic for complicated urinary tract infections.

Read more
20 Sep 2022 10:59

TOP NEWS SUMMARY: Haleon makes positive start separate from GSK

(Alliance News) - The following is a summary of top news stories Tuesday.

Read more
20 Sep 2022 09:08

TOP NEWS: Haleon makes good earnings debut with interim revenue rise

(Alliance News) - Haleon PLC on Tuesday reported a strong performance in the first half of 2022 in its first earnings report since being split from GSK PLC in July and separately listed, noting double-digit revenue growth and profit rise.

Read more
20 Sep 2022 08:58

Haleon believes it is not liable for any potential Zantac liabilities

LONDON, Sept 20 (Reuters) - Haleon believes it is not liable for any claims that may arise from U.S. litigation over the heartburn drug Zantac, the London-listed company's CEO Brian McNamara told Reuters on Tuesday.

Read more
20 Sep 2022 07:51

LONDON BRIEFING: Haleon reports double-digit revenue growth

(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.